Trials / Completed
CompletedNCT00448032
Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects
A Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Ppm-204 Administered Orally to Healthy Male Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A study evaluating the safety and pharmacokinetics of multiple oral doses of an investigational oral diabetic agent when given to healthy Japanese male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PPM-204 |
Timeline
- Start date
- 2006-11-01
- Completion
- 2007-03-01
- First posted
- 2007-03-15
- Last updated
- 2007-12-05
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00448032. Inclusion in this directory is not an endorsement.